The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial

This study aimed to investigate the medroxyprogesterone acetate (MPA)  + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who recei...

Source: Reproductive Health - October 4, 2022 Category: OBGYN Authors: Haiyan Guo, Tong Du, Hongyuan Gao, Qianwen Xi, Ling Wu, Qifeng Lyu and Qianqian Zhu Tags: Research Source Type: research